Effect of Dry Needling on Myofascial Trigger Point

Pain Clinical Trial

Official title:

The Long Term Effect of Dry Needling on Myofascial Trigger Point in the Upper Trapezius Muscle.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02107456
• Other study ID #: 920114
• Status: Completed
• Phase: N/A
• First received: April 3, 2014
• Last updated: April 7, 2014
• Start date: July 2012
• Est. completion date: June 2013

Study information

• Verified date: April 2014
• Source: University of Social Welfare and Rehabilitation Science
• Contact: n/a
• Is FDA regulated: No
• Health authority: Iran: Ethics Committee
• Study type: Interventional

Clinical Trial Summary

Myofascial trigger point is one of the most common causes of musculoskeletal disorders. Myofascial trigger point in upper trapezius has been reported as a symptom in patients with neck and upper thoracic pain. The purpose of this study was to investigate the prolonged effect of dry needling on myofascial trigger point in upper trapezius muscle.

Description:

Pain intensity and Disability of arm, hand and shoulder (DASH) were collected at base line and at the end of treatment sessions, two weeks and three months follow up in both groups.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 33
• Est. completion date: June 2013
• Est. primary completion date: February 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 20 Years to 40 Years

Eligibility

Inclusion Criteria:

• 1. Presence of a palpable taut band in muscle.

• 2. Presence of a hypersensitive tender spot in the taut band.

• 3. Reproduction of the typical referred pain pattern of the MTP in response to compression. To detect active TrPs, TrP pressure tolerance was assessed using a mechanical pressure algometer. The investigator applied continuous pressure with the algometer with an approximate pressure of 2.5 kg/cm2.

• 4. Spontaneous presence of the typical referred pain pattern and/or patient recognition of the referred pain as familiar.

• 5- Pain of at least 30 mm on a visual analogue scale (VAS). The selected MTP of the UT muscle was located in the middle of the more nearly horizontal fibers of the UT 40.

Exclusion Criteria:

• had a history of fibromyalgia syndrome, whiplash injury, cervical spine surgery and fracture, cervical radiculopathy, having therapy within the past month before the study

• any systematic disease such as rheumatism and tuberculosis or cervical myelopathy, multiple sclerosis

• local infection,

• pregnancy

• taking anticoagulants (e.g. warfarin)

• long-term steroid using

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Pain

Intervention

Device:
• Dry Needling
Dry needling was performed for one week, three times a week.

Locations

Country	Name	City	State
Iran, Islamic Republic of	University of Social Welfare and Rehabilitation Sciences	Tehran

Sponsors (1)

Lead Sponsor	Collaborator
University of Social Welfare and Rehabilitation Science

Country where clinical trial is conducted

Iran, Islamic Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain intensity	Pain intensity using visual analogue scale (VAS) were collected at base line and at the end of treatment.	One year	No
Secondary	Disability	Disability of Arm and Shoulder was collected at base line and at the end of treatment.	One year	No